Vontobel Holding
UTHR icon

Vontobel Holding’s United Therapeutics UTHR Stock Holding History

Vontobel Holding’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412K Sell
761
-52
-6% -$29.3K ﹤0.01% 1117
2026
Q1 		$482K Sell
813
-29
-3% -$14.4K ﹤0.01% 865
2025
Q4 		$410K Sell
842
-17
-2% -$7.92K ﹤0.01% 1060
2025
Q3 		$360K Sell
859
-628
-42% -$211K ﹤0.01% 1042
2025
Q2 		$427K Buy
1,487
+159
+12% +$47.5K ﹤0.01% 945
2025
Q1 		$409K Sell
1,328
-27
-2% -$9.25K ﹤0.01% 841
2024
Q4 		$478K Sell
1,355
-309
-19% -$114K ﹤0.01% 801
2024
Q3 		$596K Buy
1,664
+790
+90% +$267K ﹤0.01% 738
2024
Q2 		$278K Sell
874
-3,784
-81% -$1M ﹤0.01% 909
2024
Q1 		$1.07M Sell
4,658
-303
-6% -$68.4K 0.01% 565
2023
Q4 		$1.09M Buy
4,961
+3,834
+340% +$884K 0.01% 569
2023
Q3 		$255K Buy
1,127
+154
+16% +$35.5K ﹤0.01% 940
2023
Q2 		$215K Buy
+973
New +$216K ﹤0.01% 995
2022
Q3 		– Sell
-2,000
Closed -$477K – 1109
2022
Q2 		$477K Buy
+2,000
New +$407K 0.01% 735

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Vontobel Holding's UTHR Position: Q2 2026 in Review

Vontobel Holding reduced its United Therapeutics (UTHR) stake by 6.4% in Q2 2026, selling an estimated $29.3K and leaving 761 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Vontobel Holding first reported a position in UTHR in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.09M in Q4 2023. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Vontobel Holding held 761 shares of United Therapeutics worth $412K as of Q2 2026.
  • Vontobel Holding sold 52 United Therapeutics shares in Q2 2026, an estimated $29.3K.
  • United Therapeutics made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1117 holding.
  • Vontobel Holding first reported a position in United Therapeutics in Q2 2022 and has held it in 14 quarters since.
  • Vontobel Holding's United Therapeutics position peaked at $1.09M in Q4 2023.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.